Lung-saving surgery after pre-surgery therapy for NSCLC
Part of Cancer, Lungs & breathing clinical trials.
This trial studies how well sleeve lobectomy (a type of lung-saving surgery) works for people with non-small cell lung cancer who have already received therapy like chemotherapy or immunotherapy before surgery. It aims to see if this approach is safe and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with non-small cell lung cancer (NSCLC)
- You are scheduled for a sleeve lobectomy (a surgery that removes a lobe of the lung and a part of the airway) with the goal of curing the cancer
- You have received chemotherapy, immunotherapy, or targeted therapy before your surgery
- Your medical records are complete and you agree to be followed for at least 1 year after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving chemotherapy plus immunotherapy before surgery helps people with a specific type of advanced lung cancer. It aims to see if this approach can shrink tumors and make surgery more effective.
This study looks at a type of lung cancer surgery called sleeve lobectomy done with small incisions (minimally invasive). It aims to see if this approach is safe and effective for people with non-small cell lung cancer that requires removing a part of the lung and reconnecting the airway.
This trial looks at how well different treatments work before surgery for early-stage non-small cell lung cancer (NSCLC). It aims to help doctors understand which pre-surgery therapies lead to the best outcomes.
This trial tests whether combining chemo or targeted therapy before surgery can help people with non-small cell lung cancer that may require removing a whole lung. We want to see if this approach makes the surgery safer and more effective.
This trial tests whether combining immunotherapy with chemotherapy before robot-assisted lung surgery improves outcomes for patients with stage II–III non-small cell lung cancer. The goal is to shrink the tumor before surgery and then remove it completely using minimally invasive robotic techniques.
This trial compares two surgical approaches for advanced lung cancer (stage IIA-IIIB) after patients have already received immunotherapy and chemotherapy. Researchers want to see if removing a smaller portion of the lung (sub-lobectomy) works as well as removing an entire lobe (lobectomy), potentially reducing side effects while fighting cancer.
Hear when a new Lung cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.